title: Should we discontinue tamoxifen in a patient with vision-threatening ocular toxicity related to low-dose tamoxifen therapy?
authors.forename: D-C
authors.initials: DC
authors.lastname: Tsai
authors.forename: S-J
authors.initials: SJ
authors.lastname: Chen
authors.forename: S-H
authors.initials: SH
authors.lastname: Chiou
authors.forename: A-F
authors.initials: AF
authors.lastname: Lee
authors.forename: F-L
authors.initials: FL
authors.lastname: Lee
authors.forename: W-M
authors.initials: WM
authors.lastname: Hsu
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy; D002386:Cataract / Q000139:chemically induced*; D002387:Cataract Extraction; D004334:Drug Administration Schedule; D004965:Estrogen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D004965:Estrogen Antagonists; D013629:Tamoxifen